The slowdown came fast, steadily, and relentlessly, as seen in Intuitives subsequent quarterly commentary: Q323: In bariatrics, we continued to see double digit growth albeit at a modestly lower growth rate compared to Q2 Q423: We saw a continued deceleration in growth throughout 2023, likely the result of the uptake of GLP-1 drugs. Q124: Bariatric procedure growth continued to moderate and was flat year-over-year
Combinations can yield mixed results by individual
These vitamins may aid in fetal brain development and reduce the risk of birth defects
When beginning GLP-1 medications, its normal to encounter mild side effects such as nausea , diarrhea , vomiting , or constipation as your body gets used to the treatment
Accurate dosing is essential
We perform all of your tests in our 25,000 sq